These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31602633)
1. A decade with whole exome sequencing in haematology. Hansen MC; Haferlach T; Nyvold CG Br J Haematol; 2020 Feb; 188(3):367-382. PubMed ID: 31602633 [TBL] [Abstract][Full Text] [Related]
2. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms. Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency. Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J; J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943 [TBL] [Abstract][Full Text] [Related]
4. Detection and Characterization of Clonal Hematopoiesis. Locher BN; Löwe P; Christen F; Damm F Methods Mol Biol; 2025; 2865():449-474. PubMed ID: 39424737 [TBL] [Abstract][Full Text] [Related]
5. Role of ASXL1 in hematopoiesis and myeloid diseases. Gao X; You X; Droin N; Banaszak LG; Churpek J; Padron E; Geissler K; Solary E; Patnaik MM; Zhang J Exp Hematol; 2022 Nov; 115():14-19. PubMed ID: 36183966 [TBL] [Abstract][Full Text] [Related]
6. [Next-generation sequencing and its application in acute myeloid leukemia and myelodysplastic syndrome]. Gu SC; Chang CK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1545-9. PubMed ID: 22169322 [TBL] [Abstract][Full Text] [Related]
7. DOCK8 mutation diagnosed using whole-exome sequencing of the dried blood spot-derived DNA: a case report of an Iraqi girl diagnosed in Japan. Al-Kzayer LFY; Al-Aradi HMH; Shigemura T; Sano K; Tanaka M; Hamada M; Ali KH; Aldaghir OM; Nakazawa Y; Okuno Y BMC Med Genet; 2019 Jun; 20(1):114. PubMed ID: 31242861 [TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing in inborn errors of immunity: use the power but mind the limits. Bucciol G; Van Nieuwenhove E; Moens L; Itan Y; Meyts I Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):421-430. PubMed ID: 28938278 [TBL] [Abstract][Full Text] [Related]
9. Whole-Exome Sequencing (WES) for Illumina Short Read Sequencers Using Solution-Based Capture. Mahajan MC; McLellan AS Methods Mol Biol; 2020; 2076():85-108. PubMed ID: 31586323 [TBL] [Abstract][Full Text] [Related]
10. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Duncavage EJ; Bagg A; Hasserjian RP; DiNardo CD; Godley LA; Iacobucci I; Jaiswal S; Malcovati L; Vannucchi AM; Patel KP; Arber DA; Arcila ME; Bejar R; Berliner N; Borowitz MJ; Branford S; Brown AL; Cargo CA; Döhner H; Falini B; Garcia-Manero G; Haferlach T; Hellström-Lindberg E; Kim AS; Klco JM; Komrokji R; Lee-Cheun Loh M; Loghavi S; Mullighan CG; Ogawa S; Orazi A; Papaemmanuil E; Reiter A; Ross DM; Savona M; Shimamura A; Skoda RC; Solé F; Stone RM; Tefferi A; Walter MJ; Wu D; Ebert BL; Cazzola M Blood; 2022 Nov; 140(21):2228-2247. PubMed ID: 36130297 [TBL] [Abstract][Full Text] [Related]
12. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies. Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases. Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940 [TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing-based panel testing for myeloid neoplasms. Kuo FC; Dong F Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675 [TBL] [Abstract][Full Text] [Related]
15. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders. Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417 [TBL] [Abstract][Full Text] [Related]
17. Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise. Landstrom AP; Fernandez E; Rosenfeld JA; Yang Y; Dailey-Schwartz AL; Miyake CY; Allen HD; Penny DJ; Kim JJ Heart Rhythm; 2018 Jul; 15(7):1042-1050. PubMed ID: 29501670 [TBL] [Abstract][Full Text] [Related]
18. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach. Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947 [TBL] [Abstract][Full Text] [Related]
19. The Application of Whole-Exome Sequencing in Patients With FUO. Guo W; Feng X; Hu M; Shangguan Y; Xia J; Hu W; Li X; Zhang Z; Shi Y; Xu K Front Cell Infect Microbiol; 2021; 11():783568. PubMed ID: 35096640 [TBL] [Abstract][Full Text] [Related]
20. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies. Ye B; Sheng Y; Zhang M; Hu Y; Huang H Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]